Skip to content

Supporting Global COVID-19 Efforts

Testing can make all the difference
COVIDSeq, the first diagnostic NGS test to receive emergency use authorization from the FDA.
UCSF Charles Chiu with NextSeq
In sequencing COVID-19 strains, Dr. Chiu could have keys to the disease

When UCSF's Charles Chiu was tapped by the CDC to sequence viral strains from throughout the state, he knew he needed more capacity.

Dr Bedform of Washington
Dr. Bedford helps trace and halt community spread in Washington

With the help of Illumina NextSeq 550 and reagents, Dr. Bedford was able to identify one of the first COVID-19 clusters in the US.

sars-cov-2 graphic
How Illumina NGS can help identify and track SARS-CoV-2

Illumina has developed two workflows to detect and track SARS-CoV-2 from clinical samples.

family image

The power of NGS: from identification to vaccine development to outbreak control

NGS has the unique ability to support scientists, researchers, public health officials and health care professionals on the front lines. It helps us understand transmission routes, comorbidities, mutation rates, serves as a foundation for vaccine development and therapies, and ultimately helps predict and prevent future outbreaks.

Learn More from CMO Phil Febbo
doctor image

Connecting those who look for answers with the technology to find them

We believe access to the best technologies, global networks, and genomic insights are crucial to stop this pandemic and keep it from coming back. This is why we work with researchers, the CDC, the Chinese CDC, the NIH, GISAID, Stanford, the Broad Institute, and more to make sure they have the genomic and sequencing support they need to succeed.

Read COVID-19 Stories
face mask image

Global needs are our responsibility

We are a global company championing the greater good, committed to supporting COVID-19 efforts around the world. We are proud to partner to fund the Africa Centre of Excellence for Genomics of Infectious Diseases as well as the Milken Institute to develop global surveillance networks.

Read COVID-19 Stories
protective clothing image

Our unique ability to help

With our decades of experience, vast global reach, support across countries and languages, as well as data transparency, we are afforded a humbling opportunity to quickly connect and support local and global resources to fight this pandemic across the world.

How We Support the Fight Against COVID-19

Illumina makes software toolkit available free of charge to support worldwide efforts to combat COVID-19
Read More
Illumina’s Donation to the Africa Centre for Disease Control and Prevention Expands their Capability for Sequencing-Based COVID-19 Surveillance
Read More
UK launches whole genome sequence alliance to map spread of coronavirus
Read More
Providing the system used to sequence the first COVID‑19 genome in Wuhan
iSeq 100 System + iSeq cloud metagenomic platform to allow characterization of Cambodian COVID‑19
Read More
New York COVID-19 Genomics Research Network Coalesces to Battle Pandemic
Read More

Illumina COVID-19 Workflow Overview

Key Solutions

Shotgun Metagenomics

Allows researchers to identify novel pathogens and helps accelerate outbreak investigations.

Respiratory Pathogen Enrichment

Detects SARS-CoV-2 as well as common respiratory pathogens, and provides information about epidemiology and evolution.

Illumina COVIDSeq Test

This high-throughput NGS test detects RNA from the SARS-CoV-2 virus.

Join the conversation

Register now for a conversation with former U.S. FDA Commissioner Dr. Scott Gottlieb: “Genomics’ Role in Global COVID-19 Surveillance”

Register Now
Join the conversation